Session Details

F104 Rheum-Derm Conditions for the General Dermatologist

Mon, Mar 10, 3:30 PM - 5:30 PM
W315A
2 CME Available Forum NEW
View Map

DESCRIPTION

Open admission to eligible categories, no tuition or ticket

This course is designed to help general dermatologists recognize skin manifestations of rheumatologic diseases in their everyday practices. Learners will be able to formulate a plan including further orders/investigations needed and first line treatments.

LEARNING OBJECTIVES

1.

Recognize the most common dermatological findings in rheumatologic diseases including differentiating between cutaneous lupus and dermatomyositis

2.

Complete necessary further workup for skin findings in rheumatologic diseases

3.

Select the best treatments for the skin findings in rheumatologic diseases

SCHEDULE

7:30 PM

Mimickers of the Rheumatological Skin Diseases for the General Dermatologist

Katharina Stephanie Shaw, MD, FAAD

8:00 PM

Clinical Pearls for Sarcoidosis Diagnosis and Management

Christopher T Richardson, PhD, MD, FAAD

8:30 PM

Differences between the different Rheum/Derm Diseases

Alisa Femia, MD, FAAD

9:00 PM

Everyday Management Tips for Rheumatologic Skin Diseases

Lauren V. Graham, MD, PhD, FAAD

SPEAKERS

Alisa Femia, MD, FAAD

Alisa Femia, MD, FAAD

Lauren V. Graham, MD, PhD, FAAD

Lauren V. Graham, MD, PhD, FAAD

Christopher T Richardson, PhD, MD, FAAD

Christopher T Richardson, PhD, MD, FAAD

Katharina Stephanie Shaw, MD, FAAD

Katharina Stephanie Shaw, MD, FAAD

SPEAKER DISCLOSURES

Alisa Femia, MD, FAAD

No financial relationships exist with ineligible companies.

Lauren V. Graham, MD, PhD, FAAD

arGEN-X – Investigator(Grants/Research Funding); AstraZeneca – Consultant (1099 relationship)(Fees); Biogen – Investigator(Grants/Research Funding); clarivate – Consultant (1099 relationship)(Fees); Pfizer Inc. – Investigator(Grants/Research Funding); Regeneron – Investigator(Grants/Research Funding);

Christopher T Richardson, PhD, MD, FAAD

AstraZeneca – Investigator(Grants/Research Funding); Biogen – Advisory Board(Fees); Immunovant – Consultant (1099 relationship)(Fees); Incyte Corporation – Investigator(Grants/Research Funding); Merck – Consultant (1099 relationship)(Fees); Ribon Therapeutics – Investigator(Grants/Research Funding);

Katharina Stephanie Shaw, MD, FAAD

Priovant – Employee (w-2 relationship)(Salary);